APT Medical Inc (688617) - Total Assets
Based on the latest financial reports, APT Medical Inc (688617) holds total assets worth CN¥3.43 Billion CNY (≈ $501.99 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check APT Medical Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
APT Medical Inc - Total Assets Trend (2017–2025)
This chart illustrates how APT Medical Inc's total assets have evolved over time, based on quarterly financial data. Check 688617 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
APT Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
APT Medical Inc's total assets of CN¥3.43 Billion consist of 58.1% current assets and 41.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 34.6% |
| Accounts Receivable | CN¥93.03 Million | 2.5% |
| Inventory | CN¥491.96 Million | 13.5% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥390.36 Million | 10.7% |
| Goodwill | CN¥48.13 Million | 1.3% |
Asset Composition Trend (2017–2025)
This chart illustrates how APT Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see APT Medical Inc market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: APT Medical Inc's current assets represent 58.1% of total assets in 2025, a decrease from 63.2% in 2017.
- Cash Position: Cash and equivalents constituted 34.6% of total assets in 2025, up from 31.4% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 13.5% of total assets.
APT Medical Inc Competitors by Total Assets
Key competitors of APT Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
|
Shenzhen Lifotronic Technology Co
SHG:688389
|
China | CN¥2.53 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
APT Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.20 | 4.72 | 8.40 |
| Quick Ratio | 3.87 | 3.59 | 7.41 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.52 Billion | CN¥1.38 Billion | CN¥1.34 Billion |
APT Medical Inc - Advanced Valuation Insights
This section examines the relationship between APT Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.05 |
| Latest Market Cap to Assets Ratio | 1.08 |
| Asset Growth Rate (YoY) | 22.6% |
| Total Assets | CN¥3.66 Billion |
| Market Capitalization | $3.96 Billion USD |
Valuation Analysis
Above Book Valuation: The market values APT Medical Inc's assets above their book value (1.08x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: APT Medical Inc's assets grew by 22.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for APT Medical Inc (2017–2025)
The table below shows the annual total assets of APT Medical Inc from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.66 Billion ≈ $534.88 Million |
+22.63% |
| 2024-12-31 | CN¥2.98 Billion ≈ $436.17 Million |
+15.85% |
| 2023-12-31 | CN¥2.57 Billion ≈ $376.51 Million |
+15.59% |
| 2022-12-31 | CN¥2.23 Billion ≈ $325.73 Million |
+10.58% |
| 2021-12-31 | CN¥2.01 Billion ≈ $294.58 Million |
+241.95% |
| 2020-12-31 | CN¥588.71 Million ≈ $86.15 Million |
+4.93% |
| 2019-12-31 | CN¥561.03 Million ≈ $82.10 Million |
+72.19% |
| 2018-12-31 | CN¥325.82 Million ≈ $47.68 Million |
+28.91% |
| 2017-12-31 | CN¥252.74 Million ≈ $36.98 Million |
-- |
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more